Assignee
MABWELL SHANGHAI BIOSCIENCE CO LTD
CN·3 granted patents·11 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
14 records- 0179US10987430B2Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2017·Granted Apr 27, 2021·2 cites·28 claims
- 0259US2025059201A1Camptothecin compound and conjugate thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 0355US2023372526A1Preparation method for bis-substituted bridging antibody-drug conjugateMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 0452US2025197488A1Anti-interleukin-11 antibody and use thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 0551US2023220086A1Anti-st2 antibody and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 0647US2025269047A1Anti-human b7-h3 antibody and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 0747US2023406921A1Antibody and preparation method thereforMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 0846US2022324949A1Anti-alpha-hemolysin antibody and use thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2020·Application pending·0 cites
- 0944US12590150B2Antibody against Nectin-4 and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Granted Mar 31, 2026·0 cites·31 claims
- 1044US12558577B2Anti-human Trop-2 antibody and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2020·Granted Feb 24, 2026·0 cites·23 claims
- 1144US2023365653A1Tgf-beta rii mutant and fusion protein thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 1242US2023279115A1Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 1341US2023250168A1Anti-human claudin 18.2 antibody and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2020·Application pending·0 cites
- 1438US2023104769A1Recombinant anti-human pd-1 antibody and application thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MABWELL SHANGHAI BIOSCIENCE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →